secwatch.observer — SEC 8-K summary
======================================

Issuer:     BIO-PATH HOLDINGS, INC. (BPTH)
CIK:        0001133818
Form:       8-K
Filed at:   2023-09-15T23:59:59+00:00
Accession:  0001558370-23-015818
Event type: regulatory
Sentiment:  negative
Materiality: 0.75
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Bio-Path receives Nasdaq deficiency notice for bid price below $1.00
--------------------------------------------------------------------

- Nasdaq notified Bio-Path that closing bid price was below $1.00 for 30 consecutive business days.
- Company has 180 days, until March 11, 2024, to regain compliance by having bid price ≥ $1.00 for ten consecutive days.
- If not compliant by March 11, 2024, may seek a second 180-day cure period if eligible.
- Company may consider a reverse stock split to remedy the bid price deficiency.
- Listing on Nasdaq Capital Market under symbol BPTH is unaffected during cure period.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1133818/000155837023015818/0001558370-23-015818-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1133818/000155837023015818/bpth-20230913x8k.htm
  HTML page:      https://secwatch.observer/filing/0001558370-23-015818

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer